T2 Biosystems Regains Compliance with NASDAQ Listing Requirements
T2 Biosystems, Inc. (TTOO)
Last t2 biosystems, inc. earnings: 2/24 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.t2biosystems.com/phoenix.zhtml?c=253528&p=irol-faq
Company Research
Source: GlobeNewswire
LEXINGTON, Mass., June 17, 2020 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that on June 16, 2020 it received written notice from the Nasdaq Listing Qualifications Staff of the NASDAQ Stock Market LLC (“Nasdaq”) stating that the Company regained compliance with the applicable Nasdaq minimum bid price continued listing requirement and the matter is now closed. The Company had previously been notified by Nasdaq on April 7, 2020 that it was not in compliance with the minimum bid price requirement because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. In order to regain compliance with Nasdaq Listing Rule 5450(a)(1), the Company was required to maintain a minimum closing bid price of $1.00 or more for at least 10 consecutive trading days, which was achieved on June 15, 2020 when the Company’s closing bid price was $1.63. About T2 Biosystems T2 Bio
Show less
Read more
Impact Snapshot
Event Time:
TTOO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TTOO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TTOO alerts
High impacting T2 Biosystems, Inc. news events
Weekly update
A roundup of the hottest topics
TTOO
News
- T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease [Yahoo! Finance]Yahoo! Finance
- T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme DiseaseGlobeNewswire
- T2 Biosystems Announces First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- T2 Biosystems Announces the Conversion of an Additional $15 Million of CRG Term Loan into Equity [Yahoo! Finance]Yahoo! Finance
- T2 Biosystems Announces Commercial Expansion Through Middle East DistributorGlobeNewswire
TTOO
Analyst Actions
- 4/29/24 - Canaccord Genuity
TTOO
Sec Filings
- 5/8/24 - Form FWP
- 5/7/24 - Form SC
- 5/7/24 - Form 4
- TTOO's page on the SEC website